Search Tag: breast cancer diagnosis
2024 26 Sep
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find CME On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/cmescience target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><aRead more
2023 02 Aug
A new study published in The Lancet Oncology showed that AI is safe to use in breast cancer detection and could assist doctors with finding cancer more effectively. The new research is believed to be the first-ever randomized control trial comparing AI-assisted breast cancer detection with detection solely performed by experienced humans. ...Read more
2023 02 Aug
A new study published in The Lancet Oncology showed that AI is safe to use in breast cancer detection and could assist doctors with finding cancer more effectively. The new research is believed to be the first-ever randomized control trial comparing AI-assisted breast cancer detection with detection solely performed by experienced humans. ...Read more
2019 30 Apr
Breast health leader will highlight expanding portfolio for breast conserving surgery Hologic, Inc. will showcase its growing breast surgery franchise, which includes products such as the new Trident® HD specimen radiography system, LOCalizer™ wire-free guidance system and the BioZorb® marker, in Booth #103 at the 20th Annual Meeting of...Read more
2019 26 Apr
Company expands breast specimen imaging portfolio and leadership in breast cancer diagnosis and care. Hologic, Inc. today announced global commercial availability of the Trident ® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during...Read more
2016 21 Jun
A combination of the decades-long practice of diagnosing illnesses by manually reviewing images under a microscope and artificial intelligence (AI), can help doctors improve accuracy of breast and other cancer diagnosis to a rate of 99.5 percent. A research team from Beth Israel Deaconess Medical Center (BIDMC) in Boston and Harvard Medical...Read more